Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-23-025083

Options or other derivatives

  • Director acquired 24,417 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kornberg Roger D. Director 2023-07-18 Grant or award · Stock Options (Right to Buy) +24,417 24,417 D
Loading xslF345X05/ownership.xml…